The European Circular Bio­economy Fund, which aims to provide financing for innovative circular bioeconomy companies and projects in the EU and in countries associated with the Horizon 2020 programme, will be headed by Michael Brandkamp.

At the 15th Annual Scrip Awards, Mogrify Chair Jane Osbourn has been presented with the Lifetime Achievement Award. She received the award in recognition of her outstanding contribution to the biotech industry throughout her career.

Claus Haberda will be the new Managing Director at Roche Diagnostics GmbH, succeeding Ursula Redeker, who will return to Basel.

John Mattick has been appointed to the Board of Directors of Oxford-based research company Arctoris Ltd.

Swiss Lonza announced that CEO Marc Funk is leaving the company. Chairman Albert Baehny will take over as CEO on an ad interim basis until a successor is found.

Nosopharm, a company dedicated to the research and development of new anti-infective drugs, has named Jacques Biton as its new chairman of the board, taking over from Gilles Alberici.

Swiss specialty pharmaceutical company Santhera has named Dario Eklund as new CEO. Eklund joins from Vifor Pharma, where he served as Chief Commercial Officer.

Renowned immunologist Iain McInnes has been appointed to the Scientific Advisory Boar of Oxford BioDynamics Plc, where he joins Karol Sikora, Jane Mellor and Lucien Peng-Jin Ooi.

Amarna Therapeutics  has appointed a new Supervisory Board, led by healthcare and biotech pioneer Thomas Eldered.

Diabeloop CEO Marc Julien has won the EIT Innovators Award.